NEW YORK (GenomeWeb News) — Alnylam said today it has granted a non-exclusive license for its Kreutzer-Limmer siRNA patents to Hayashi Kasei, an siRNA supplier in Japan and Korea.
 
Under the agreement, the Osaka, Japan-based Hayashi Kasei will be able to use the siRNAi patents to provide RNAi research products and services, Alnylam said.
 
Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.